Meanwhile, the positive results in PKU are a boost for Synlogic's biotherapeutic strategy, which will be tested further later this year with the readout of its phase 1 trial of homocystinuria (HCU ...

and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a collaboration agreement with ...